METHODS AND PHARMACEUTICAL COMPOSITIONS FOR IMMUNE DECEPTION, PARTICULARLY USEFUL IN THE TREATMENT OF CANCER

Details for Australian Patent Application No. 2002304279 (hide)

Event Publications

19 December 2002 Complete Application Filed

Priority application(s): 60/298,915 19.06.01 US; 10/108,511 29.03.02 US

15 May 2003 Application Open to Public Inspection

Published as AU-A-2002304279

7 April 2005 Assignment before Grant

Technion Research and Development Foundation Ltd. The application has been assigned to Teva Pharmaceutical Industries Ltd.

14 April 2005 Assignment before Grant

Teva Pharmaceutical Industries Ltd. The application has been assigned to Teva Pharmaceutical Industries Ltd.; Technion Research and Development Foundation Ltd.

11 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.